Scientific Advisor Board

Bertram Pitt, MD, Chief of Scientific Advisory Board

One of the most well-known cardiologists in the country who is involved in every major cardiovascular clinical trial over the last five decades, including commonly used classes of drugs such as MRAs, ACEis, ARBs, SGLT2is, and loop diuretics. He is responsible for clinical trials, interactions with key opinion leaders, and FDA presentations.

Chris Wilcox, MD, PhD, Chief Scientific Advisor

A Preeminent physician-scientist who has advised almost every major pharmaceutical company in the world on clinical development of cardio-renal products including recently launched Farxiga®, Entresto®, and Lasix®. He is responsible for the development of clinical strategy, protocol development, trial data interpretation and analytics.